Literature DB >> 1751920

A need for evaluation.

.   

Abstract

Mesh:

Year:  1991        PMID: 1751920      PMCID: PMC1335853     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Economic evaluation of extracorporeal shock wave lithotripsy, percutaneous ultrasonic lithotripsy, and standard surgical treatment of urolithiasis--a Canadian perspective.

Authors:  R J Labelle; D N Churchill; S Martin; E Isbister; W Orovan
Journal:  Clin Invest Med       Date:  1987-03       Impact factor: 0.825

Review 2.  Bioeffects of extracorporeal shock-wave lithotripsy. Strategy for research and treatment.

Authors:  J E Lingeman; J A McAteer; S A Kempson; A P Evan
Journal:  Urol Clin North Am       Date:  1988-08       Impact factor: 2.241

3.  A cost-effectiveness analysis of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy.

Authors:  P Carlsson; J Nauclér; S Petterson; H G Tiselius
Journal:  Scand J Urol Nephrol Suppl       Date:  1989

Review 4.  Extracorporeal shock wave lithotripsy. An update.

Authors:  W T Wilson; G M Preminger
Journal:  Urol Clin North Am       Date:  1990-02       Impact factor: 2.241

5.  From "promising report" to "standard procedure": seven stages in the career of a medical innovation.

Authors:  J B McKinlay
Journal:  Milbank Mem Fund Q Health Soc       Date:  1981

6.  Short-term changes of laboratory values after extracorporeal shock wave lithotripsy: a comparative study.

Authors:  G Haupt; A Haupt; J M Donovan; G W Drach; C Chaussy
Journal:  J Urol       Date:  1989-08       Impact factor: 7.450

7.  Absence of persisting parenchymal damage after extracorporeal shock wave lithotripsy as judged by excretion of renal tubular enzymes.

Authors:  G S Karlin; D Schulsinger; M Urivetsky; A D Smith
Journal:  J Urol       Date:  1990-07       Impact factor: 7.450

8.  Cost-effectiveness of extracorporeal shock-wave lithotripsy.

Authors:  L J Aronne; R L Braham; R Riehle; E D Vaughan; H S Ruchlin
Journal:  Urology       Date:  1988-03       Impact factor: 2.649

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.